Fig 1.
Flow diagram of included/excluded studies.
Table 1.
Summary of meta-analysis and subgroups analysis results of the elevated ePASP prevalence among adults with SCD.
Fig 2.
The forest plot of the prevalence of elevated ePASP by the primary studies in adults, and the overall estimate (95% CI).
Table 2.
Summary of meta-analysis and subgroups analysis results of the elevated ePASP prevalence among children with SCD.
Fig 3.
The forest plot of the prevalence of elevated ePASP by the primary studies in children, and the overall estimate (95% CI).
Table 3.
Summary of meta-analysis of the clinical and laboratory results among adults with SCD comparing elevated ePASP than those without.
Table 4.
Summary of meta-analysis of the clinical and laboratory results among children with SCD comparing elevated ePASP than those without.